Compounds and methods targeting interleukin-34

The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.

Saved in:
Bibliographic Details
Main Authors FLEISHER Adam S, LANNAN Megan Brittany, LO Albert, SIMS John Randall II, SKORA Andrew Dixon, OBUNGU Victor H, MINTUN Mark, CHEDID Marcio, WALSH Robin Elizabeth, RAINES Sarah Elisabeth, WEST Elizabeth Anne, YE Ming
Format Patent
LanguageEnglish
Hebrew
Published 01.06.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
Bibliography:Application Number: IL20240312380